In Brief
Eating disorders are more common in individuals with type 1 diabetes than in the general population. Although limited research has been conducted in this area, existing evidence shows that these conditions significantly affect the physical and emotional health of individuals with diabetes and are associated with impaired metabolic control and a high risk of medical complications, including higher mortality rates. New nomenclature was recommended at an international focus group held in Minneapolis, Minn., in September 2008. Composed of individuals with interest and expertise in eating disorders among individuals with diabetes, the group recommended that the term ED-DMT1 be used to designate those with an eating disorder and type 1 diabetes and ED-DMT2 be used for those with an eating disorder and type 2 diabetes. This article provides an overview of clinical features, consequences, and pathways of risk associated with ED-DMT1.